Patent ID: 9737489
Date: 2017-08-22
CPC Classifications: A61K,H05K

Claim:
1. A method of treating a human subject with ulcerative colitis, comprising administering to said human subject an oral pharmaceutical composition in the form of a tablet consisting essentially of: (a) a tablet core comprising granules, said granules comprising 9 mg of budesonide, at least one lipophilic or inert matrix, and at least one amphiphilic matrix, wherein said granules are dispersed in a composition comprising at least one hydrophilic matrix; and (b) a tablet coating comprising a gastro-resistant film, wherein said gastro-resistant film comprises a plasticizer and at least one methacrylic acid copolymer; and wherein said oral pharmaceutical composition provides a C max of said budesonide in said human subject of about 1.35±0.96 ng/mL following said administration of said oral pharmaceutical composition to said human subject.